FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke
The FINANCIAL -- AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability ...
ADVERTISEMENT
Tag: US Food and Drug Administration
FDA fully approved Venclexta combinations for acute myeloid leukaemia
The FINANCIAL -- Roche today announced that the US Food and Drug Administration (FDA) has granted full approval of Venclexta® (venetoclax) ...
ADVERTISEMENT
Popular Last 24h
-
Ampersand wins £22m five-year contract at London Zoo
-
Putin Rejects Ceasefire Proposal, Casting Doubt on Russia’s Intentions
-
Optimist Fund Exits Following Xponential Fitness’ Founder-CEO Resignation
-
Jordan Fried’s Mission to Transform Puerto Rico Through Entrepreneurship
-
LDN: The Anti-Inflammatory and Longevity Potential of Low Dose Naltrexone
-
Trump launches cryptocurrency with price rocketing
-
SEC Crypto 2.0: Acting Chairman Uyeda Announces Formation of New Crypto Task Force
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
